Skip to content
OpenCapital
Get started

GoodRx Holdings, Inc. GDRX Prescription transactions revenue — Revenue

Other product segments

Pharma manufacturer solutions revenue
$151.38M—
Pharma Direct revenue
$52.23M+82.3%
Subscription revenue
$24.39M+16.1%
Other revenue
$3.69M-15.8%

Similar metrics at other companies

McKesson logo
MCKPrescription Technology Solutions — Revenue derived from services (less than) (as a percent)
7%0.0pp
Weis Markets logo
WMKPharmacy — Revenue
$165.04M+11.4%
CVS Health logo
CVSProducts — Revenue
$62.23B+7.9%
Chime Financial, Inc. Class A Common Stock logo
CHYMPayments revenue — Revenue
$432.64M+15.3%
Albertsons Companies logo
ACIPharmacy — Net sales and other revenue
$2.69B+18.9%
AMP
AMPHPharmaceutical Products — Revenue
$171.17M+0.4%

Other financials

Income statement

See full
Revenue$194.0M-4.4%
Gross profit$173.9M-8.3%
Operating income$14.0M-40.1%
Net income$1.2M-89.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$235.7M-21.7%
Total debt$541.4M0.0%
Total equity$622.0M-4.9%
Total assets$2.0B+56.0%

Cash flow

See full
Operating cash flow$11.8M+25.8%
CapEx$1.1M+700%
Free cash flow$10.7M+15.4%

Valuation

See full
Market cap$934.74M-43.1%
Enterprise value$1.24B-34.1%
P/E45.5×-12.3×
P/S1.2×-0.9×

Profitability

See full
Gross margin91.8%-2.0pp
Operating margin9.9%-0.3pp
Net margin2.6%-1.0pp
FCF margin21%+2.3pp

Returns & leverage

See full
Return on equity3.2%-1.2pp
Debt / equity0.9×0.0×
Current ratio1.5×-3.8×

Where this comes from

Reported directly by GoodRx Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about GoodRx Holdings, Inc.'s prescription transactions revenue — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GoodRx Holdings, Inc.'s prescription transactions revenue — revenue?
GoodRx Holdings, Inc. (GDRX) reported prescription transactions revenue — revenue of $113.69M in Q1 2026.
How has GoodRx Holdings, Inc.'s prescription transactions revenue — revenue changed year-over-year?
GoodRx Holdings, Inc.'s prescription transactions revenue — revenue decreased by 23.7% year-over-year, from $148.92M to $113.69M.
What is the long-term trend for GoodRx Holdings, Inc.'s prescription transactions revenue — revenue?
Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s prescription transactions revenue — revenue has grown at a -2.1% compound annual growth rate (CAGR), from $593.36M to $544M.
What does prescription transactions revenue — revenue mean?
This metric represents the total revenue generated from prescription transaction services, primarily derived from fees paid by pharmacy benefit managers or other partners when consumers use the platform to access negotiated drug prices. It serves as a key indicator of the platform's ability to monetize prescription volume and capture value from facilitating healthcare cost savings. Growth in this metric reflects successful user adoption and effective partnership monetization within the digital pharmacy marketplace.